FaceStation Study

The purpose of this study is to determine the tolerability and therapeutic potential of oxytocin in children and adolescents with ASD when paired with a computer game intervention that is designed to enhance face perception skills.

What is the study?

FaceStation is a game system specifically designed to help people with ASD become better at recognizing faces and facial expressions, and to better attend to direction of eye gaze. The study will be investigating the effects of intranasal oxytocin on face training, such as recognizing a person's identity or emotion.

What is the drug?

The drug is intranasal oxytocin. Oxytocin is a naturally occurring hormone. It will be provided to participants at no charge in the form of a nasal spray. It is being investigated to see if it helps people with autism by improving social behaviors.

Who can be in the study?

Males ages 12-17, diagnosed with an autism spectrum disorder, that have not recently changed medications.

How long is the study?

The study will last up to 12 days.

What are participants in the study asked to do?

As a participant you would be required to:

  • Attend study visits: screening, baseline, and follow-up
  • Take study drug as instructed
  • Play the FaceStation games for approximately two hours on 5 days within an 8 day period; either at home or in the clinic

Study team

Principal Investigator (PI):

Study status

In progress, but not enrolling


  • Males, ages 12-17
  • Diagnosed with an autism spectrum disorder
  • Have not recently changed medications